K. Sigurdsson

666 total citations
18 papers, 334 citations indexed

About

K. Sigurdsson is a scholar working on Epidemiology, Surgery and Reproductive Medicine. According to data from OpenAlex, K. Sigurdsson has authored 18 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 5 papers in Surgery and 4 papers in Reproductive Medicine. Recurrent topics in K. Sigurdsson's work include Cervical Cancer and HPV Research (8 papers), Genital Health and Disease (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). K. Sigurdsson is often cited by papers focused on Cervical Cancer and HPV Research (8 papers), Genital Health and Disease (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). K. Sigurdsson collaborates with scholars based in Iceland, Sweden and Denmark. K. Sigurdsson's co-authors include J. E. Johnsson, G Geirsson, Claes G. Tropé, Jón Hrafnkelsson, Johannes Gudmundsson, Claes G. Tropé, S Moss, C. Tropé, W. Mattsson and Hrafn Tulinius and has published in prestigious journals such as International Journal of Cancer, European Journal of Cancer and Gynecologic Oncology.

In The Last Decade

K. Sigurdsson

18 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Sigurdsson Iceland 10 224 135 94 61 53 18 334
L McGowan United States 8 199 0.9× 69 0.5× 67 0.7× 81 1.3× 65 1.2× 25 330
Efrén Javier Domingo Philippines 9 227 1.0× 126 0.9× 103 1.1× 81 1.3× 54 1.0× 14 374
Michele F. Mitchell United States 10 183 0.8× 97 0.7× 219 2.3× 146 2.4× 146 2.8× 12 482
Doris Schledermann Denmark 12 192 0.9× 98 0.7× 144 1.5× 73 1.2× 121 2.3× 28 353
Sun Kuie Tay Singapore 11 207 0.9× 70 0.5× 51 0.5× 76 1.2× 59 1.1× 23 349
Kung-Liahng Wang Taiwan 10 198 0.9× 116 0.9× 145 1.5× 80 1.3× 163 3.1× 18 392
Mahalakshmi Gurumurthy United Kingdom 10 109 0.5× 70 0.5× 87 0.9× 119 2.0× 80 1.5× 21 274
Pissamai Yuenyao Thailand 14 326 1.5× 107 0.8× 90 1.0× 149 2.4× 37 0.7× 25 464
Joseph D. Carreon United States 9 361 1.6× 108 0.8× 184 2.0× 173 2.8× 65 1.2× 11 518
Brittany Lees United States 8 123 0.5× 66 0.5× 163 1.7× 56 0.9× 115 2.2× 14 320

Countries citing papers authored by K. Sigurdsson

Since Specialization
Citations

This map shows the geographic impact of K. Sigurdsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Sigurdsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Sigurdsson more than expected).

Fields of papers citing papers by K. Sigurdsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Sigurdsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Sigurdsson. The network helps show where K. Sigurdsson may publish in the future.

Co-authorship network of co-authors of K. Sigurdsson

This figure shows the co-authorship network connecting the top 25 collaborators of K. Sigurdsson. A scholar is included among the top collaborators of K. Sigurdsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Sigurdsson. K. Sigurdsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sigurdsson, K., et al.. (2023). Are orofacial pain and xerostomia associated with differences in diet, sensory perception, appetite and enjoyment of eating?—An explorative study. Journal of Oral Rehabilitation. 51(4). 703–711. 3 indexed citations
2.
Sigurdsson, K.. (2013). Is a liquid‐based cytology more sensitive than a conventional Pap smear?. Cytopathology. 24(4). 254–263. 27 indexed citations
3.
Sigurdsson, K.. (2010). Cervical cancer: cytological cervical screening in Iceland and implications of HPV vaccines. Cytopathology. 21(4). 213–222. 11 indexed citations
4.
Majewski, Sławomir, FX Bosch, Joakim Dillner, et al.. (2009). The impact of a quadrivalent human papillomavirus (types 6, 11, 16, 18) virus‐like particle vaccine in European women aged 16 to 24. Journal of the European Academy of Dermatology and Venereology. 23(10). 1147–1155. 26 indexed citations
5.
Sigurdsson, K.. (1999). [The Nordic cervical screening programmes through 1995. Evaluation of incidence and mortality rates, targeted age groups and screening intervals.].. PubMed. 85(11). 862–72. 2 indexed citations
6.
Sigurdsson, K., et al.. (1996). Human papillomavirus (HPV) in an Icelandic population: correlation of HPV DNA to cyto- and histopathologic lesions and evaluation of treatment strategies. International Journal of Gynecological Cancer. 6(3). 175–182. 7 indexed citations
7.
Sigurdsson, K.. (1995). Quality assurance in cervical cancer screening: The Icelandic experience 1964–1993. European Journal of Cancer. 31(5). 728–734. 33 indexed citations
8.
Sigurdsson, K.. (1993). Effect of organized screening on the risk of cervical cancer. Evaluation of screening activity in iceland, 1964–1991. International Journal of Cancer. 54(4). 563–570. 98 indexed citations
9.
10.
Sigurdsson, K., et al.. (1991). Cervical intra-epithelial neoplasia and koilocytotic lesions of the lower genitalia in an Icelandic population. International Journal of Gynecological Cancer. 1(2). 49–57. 6 indexed citations
11.
Geirsson, G, et al.. (1986). Cervical cancer screening in Iceland: a case-control study.. PubMed. 37–41. 17 indexed citations
12.
Sigurdsson, K., J. E. Johnsson, & Claes G. Tropé. (1982). Carcinoma of the ovary, stages I and II. A prospective randomized study of the effects of postoperative chemotherapy and radiotherapy.. PubMed. 71(6). 321–9. 17 indexed citations
13.
Tropé, Claes G. & K. Sigurdsson. (1982). Use of tissue culture in predictive testing of drug sensitivity in human ovarian cancer. Correlation between in vitro results and the response in vivo.. PubMed. 29(3). 309–14. 2 indexed citations
14.
Tropé, Claes G., et al.. (1982). [Bleomycin combined with mitomycin C in recurrent cervix cancer].. PubMed. 79(17). 1689–91. 5 indexed citations
15.
Tropé, Claes G., et al.. (1982). High-dose medroxyprogesterone acetate for the treatment of advanced ovarian carcinoma.. PubMed. 66(6). 1441–3. 21 indexed citations
16.
Sigurdsson, K., J. E. Johnsson, & Claes G. Tropé. (1982). Carcinoma of the Ovary in Stage III: Effects of Postoperative Chemotherapy, Radiation Therapy and Repeat Laparotomy. Acta Radiologica Oncology. 21(3). 181–189. 2 indexed citations
17.
Tropé, C., et al.. (1981). Phase II study of spirogermanium in advanced ovarian malignancy.. PubMed. 65(1-2). 119–20. 18 indexed citations
18.
Sigurdsson, K.. (1977). [Abortions at Nacka Hospital, 1975--somatic complications and preventive technics].. PubMed. 74(5). 318–21. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026